News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-18 4:1:57 am First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference GlobeNewsWire
2024-03-14 3:0:0 am First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline GlobeNewswire
2024-03-05 4:0:0 am First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference GlobeNewswire
2024-03-04 5:0:0 am First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering GlobeNewswire
2024-02-13 4:0:0 am First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024 GlobeNewswire
2024-01-23 4:0:0 am First Wave BioPharma to Present at the DealFlow MicroCap Conference GlobeNewswire
2024-01-17 4:0:0 am First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico GlobeNewswire
2024-01-04 3:0:0 am First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024 GlobeNewswire
2023-12-27 8:55:0 am First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information